Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 13 | 93293605 | intron variant | A/T | snv | 1.5E-02 |
|
Nervous System Diseases; Mental Disorders | 0.800 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.040 | 13 | 93756253 | intron variant | A/G | snv | 0.68 |
|
Mental Disorders | 0.800 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.040 | 13 | 94300578 | intron variant | T/C;G | snv |
|
Musculoskeletal Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
13 | 93244682 | intron variant | G/A | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
13 | 93260737 | intron variant | C/T | snv | 0.57 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
13 | 93838807 | intron variant | A/G | snv | 7.1E-02 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 13 | 93226778 | non coding transcript exon variant | A/G | snv | 3.7E-02 |
|
Nervous System Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 13 | 93226778 | non coding transcript exon variant | A/G | snv | 3.7E-02 |
|
0.700 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 13 | 93226778 | non coding transcript exon variant | A/G | snv | 3.7E-02 |
|
0.700 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 13 | 93226778 | non coding transcript exon variant | A/G | snv | 3.7E-02 |
|
0.700 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 13 | 93226778 | non coding transcript exon variant | A/G | snv | 3.7E-02 |
|
0.700 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
13 | 93580876 | intron variant | A/C | snv | 0.77 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
13 | 93980567 | intron variant | G/A | snv | 0.17 |
|
Nutritional and Metabolic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 0.040 | 13 | 93358916 | intron variant | A/G | snv | 0.15 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 13 | 93358916 | intron variant | A/G | snv | 0.15 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 13 | 93774100 | intron variant | A/G | snv | 0.29 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
13 | 94403472 | 3 prime UTR variant | G/A | snv | 4.0E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
13 | 94403472 | 3 prime UTR variant | G/A | snv | 4.0E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
1.000 | 0.120 | 13 | 93830534 | stop gained | C/T | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases | 0.700 | 0 | ||||||||||
|
1.000 | 0.120 | 13 | 94027795 | frameshift variant | C/- | del |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases | 0.700 | 0 | |||||||||||
|
0.925 | 0.120 | 13 | 93224864 | upstream gene variant | A/G | snv | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 13 | 93224864 | upstream gene variant | A/G | snv | 0.16 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |